William Blair analyst Matt Phipps reiterated a Hold rating on Amgen (AMGN – Research Report) yesterday. The company’s shares closed
Category: Healthcare
William Blair Sticks to Its Buy Rating for Autolus Therapeutics (AUTL)
In a report released yesterday, Matt Phipps from William Blair reiterated a Buy rating on Autolus Therapeutics (AUTL – Research
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (NASDAQ: AMGN), Neurocrine (NASDAQ: NBIX) and Ovid Therapeutics (NASDAQ: OVID)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN –
Cellectis SA (CLLS) Gets a Buy Rating from JonesTrading
JonesTrading analyst Soumit Roy reiterated a Buy rating on Cellectis SA (CLLS – Research Report) today. The company’s shares closed
TFF Pharmaceuticals (TFFP) Receives a New Rating from a Top Analyst
Maxim Group analyst Jason McCarthy assigned a Buy rating to TFF Pharmaceuticals (TFFP – Research Report) yesterday and set a
Oppenheimer Remains a Buy on Cellectis SA (CLLS)
In a report released today, Hartaj Singh from Oppenheimer maintained a Buy rating on Cellectis SA (CLLS – Research Report),
Inventiva (IVA) Gets a Buy Rating from Stifel Nicolaus
Stifel Nicolaus analyst Derek Archila reiterated a Buy rating on Inventiva (IVA – Research Report) today and set a price